GLS and non-small cell lung carcinoma: In order to perform a survival analysis of NSCLC, we gathered clinical information on lung adenocarcinoma patients from The Cancer Genome Atlas (TCGA).12 Kaplan–Meier analysis demonstrated that higher than average expression levels in GLS1 and thymidylate synthase (TYMS) gene expression were associated with poorer overall survival.